NEJM:抗药性局灶性癫痫的组织病理学研究

2017-10-26 zhangfan MedSci原创

对于接受手术治疗的抗药性局灶性癫痫患者,海马硬化是成人最常见的组织病理学诊断,而中枢性皮质发育不良是儿童最常见的诊断。肿瘤是成年及未成年患者中次常见病变

结构性脑损伤癫痫发作的详细病理信息对于理解耐药性癫痫十分关键。

近日研究人员公布了1份癫痫手术患者的脑切除标本报告。该报告包含9523名患者,来自12个欧洲国家的36个医疗中心,研究持续25年,其中41%组织病理学诊断在当地医院进行,59%的诊断在德国神经病理学参考中心进行。

75.9%的患者其癫痫发作年龄早于18岁,但72.5%的患者在成年后接受手术治疗。术前癫痫平均持续时间为成人20.1年,儿童5.3年。71.9%的手术涉及颞叶。研究共得出36种组织病理学诊断和7种主要疾病,最常见的组织病理学诊断为海马硬化,占36.4%(成人比例为88.7%)、肿瘤(主要神经节胶质细胞瘤),占23.6%、皮质发育畸形(局灶性皮质发育不良是最常见的类型,儿童比例为52.7%),占19.8%。7.7%的患者无明确的组织病理学诊断。

对于接受手术治疗的抗药性局灶性癫痫患者,海马硬化是成人最常见的组织病理学诊断,而中枢性皮质发育不良是儿童最常见的诊断。肿瘤是成年及未成年患者中次常见病变。

原始出处:

Ingmar Blumcke et al. Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery. N Engl J Med. October 26, 2017.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1928811, encodeId=50151928811c3, content=<a href='/topic/show?id=71f1e771115' target=_blank style='color:#2F92EE;'>#组织病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77711, encryptionId=71f1e771115, topicName=组织病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun May 27 11:07:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748440, encodeId=2e591e4844016, content=<a href='/topic/show?id=f4f54e58401' target=_blank style='color:#2F92EE;'>#局灶性癫痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47584, encryptionId=f4f54e58401, topicName=局灶性癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9dab36126219, createdName=JR19860231, createdTime=Wed Jan 17 04:07:00 CST 2018, time=2018-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009679, encodeId=0ffa20096e9b6, content=<a href='/topic/show?id=c7804e581bc' target=_blank style='color:#2F92EE;'>#局灶性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47581, encryptionId=c7804e581bc, topicName=局灶性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Mon Jul 16 11:07:00 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473448, encodeId=3e4f14e3448a2, content=<a href='/topic/show?id=4fd1e102257' target=_blank style='color:#2F92EE;'>#病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71022, encryptionId=4fd1e102257, topicName=病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8ce7226273, createdName=jktdtl, createdTime=Sat Oct 28 01:07:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495381, encodeId=a15114953817f, content=<a href='/topic/show?id=cdd8556826f' target=_blank style='color:#2F92EE;'>#抗药性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55682, encryptionId=cdd8556826f, topicName=抗药性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=110a9169530, createdName=songbq, createdTime=Sat Oct 28 01:07:00 CST 2017, time=2017-10-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1928811, encodeId=50151928811c3, content=<a href='/topic/show?id=71f1e771115' target=_blank style='color:#2F92EE;'>#组织病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77711, encryptionId=71f1e771115, topicName=组织病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun May 27 11:07:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748440, encodeId=2e591e4844016, content=<a href='/topic/show?id=f4f54e58401' target=_blank style='color:#2F92EE;'>#局灶性癫痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47584, encryptionId=f4f54e58401, topicName=局灶性癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9dab36126219, createdName=JR19860231, createdTime=Wed Jan 17 04:07:00 CST 2018, time=2018-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009679, encodeId=0ffa20096e9b6, content=<a href='/topic/show?id=c7804e581bc' target=_blank style='color:#2F92EE;'>#局灶性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47581, encryptionId=c7804e581bc, topicName=局灶性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Mon Jul 16 11:07:00 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473448, encodeId=3e4f14e3448a2, content=<a href='/topic/show?id=4fd1e102257' target=_blank style='color:#2F92EE;'>#病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71022, encryptionId=4fd1e102257, topicName=病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8ce7226273, createdName=jktdtl, createdTime=Sat Oct 28 01:07:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495381, encodeId=a15114953817f, content=<a href='/topic/show?id=cdd8556826f' target=_blank style='color:#2F92EE;'>#抗药性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55682, encryptionId=cdd8556826f, topicName=抗药性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=110a9169530, createdName=songbq, createdTime=Sat Oct 28 01:07:00 CST 2017, time=2017-10-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1928811, encodeId=50151928811c3, content=<a href='/topic/show?id=71f1e771115' target=_blank style='color:#2F92EE;'>#组织病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77711, encryptionId=71f1e771115, topicName=组织病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun May 27 11:07:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748440, encodeId=2e591e4844016, content=<a href='/topic/show?id=f4f54e58401' target=_blank style='color:#2F92EE;'>#局灶性癫痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47584, encryptionId=f4f54e58401, topicName=局灶性癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9dab36126219, createdName=JR19860231, createdTime=Wed Jan 17 04:07:00 CST 2018, time=2018-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009679, encodeId=0ffa20096e9b6, content=<a href='/topic/show?id=c7804e581bc' target=_blank style='color:#2F92EE;'>#局灶性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47581, encryptionId=c7804e581bc, topicName=局灶性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Mon Jul 16 11:07:00 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473448, encodeId=3e4f14e3448a2, content=<a href='/topic/show?id=4fd1e102257' target=_blank style='color:#2F92EE;'>#病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71022, encryptionId=4fd1e102257, topicName=病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8ce7226273, createdName=jktdtl, createdTime=Sat Oct 28 01:07:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495381, encodeId=a15114953817f, content=<a href='/topic/show?id=cdd8556826f' target=_blank style='color:#2F92EE;'>#抗药性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55682, encryptionId=cdd8556826f, topicName=抗药性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=110a9169530, createdName=songbq, createdTime=Sat Oct 28 01:07:00 CST 2017, time=2017-10-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1928811, encodeId=50151928811c3, content=<a href='/topic/show?id=71f1e771115' target=_blank style='color:#2F92EE;'>#组织病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77711, encryptionId=71f1e771115, topicName=组织病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun May 27 11:07:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748440, encodeId=2e591e4844016, content=<a href='/topic/show?id=f4f54e58401' target=_blank style='color:#2F92EE;'>#局灶性癫痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47584, encryptionId=f4f54e58401, topicName=局灶性癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9dab36126219, createdName=JR19860231, createdTime=Wed Jan 17 04:07:00 CST 2018, time=2018-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009679, encodeId=0ffa20096e9b6, content=<a href='/topic/show?id=c7804e581bc' target=_blank style='color:#2F92EE;'>#局灶性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47581, encryptionId=c7804e581bc, topicName=局灶性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Mon Jul 16 11:07:00 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473448, encodeId=3e4f14e3448a2, content=<a href='/topic/show?id=4fd1e102257' target=_blank style='color:#2F92EE;'>#病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71022, encryptionId=4fd1e102257, topicName=病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8ce7226273, createdName=jktdtl, createdTime=Sat Oct 28 01:07:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495381, encodeId=a15114953817f, content=<a href='/topic/show?id=cdd8556826f' target=_blank style='color:#2F92EE;'>#抗药性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55682, encryptionId=cdd8556826f, topicName=抗药性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=110a9169530, createdName=songbq, createdTime=Sat Oct 28 01:07:00 CST 2017, time=2017-10-28, status=1, ipAttribution=)]
    2017-10-28 jktdtl
  5. [GetPortalCommentsPageByObjectIdResponse(id=1928811, encodeId=50151928811c3, content=<a href='/topic/show?id=71f1e771115' target=_blank style='color:#2F92EE;'>#组织病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77711, encryptionId=71f1e771115, topicName=组织病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun May 27 11:07:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748440, encodeId=2e591e4844016, content=<a href='/topic/show?id=f4f54e58401' target=_blank style='color:#2F92EE;'>#局灶性癫痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47584, encryptionId=f4f54e58401, topicName=局灶性癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9dab36126219, createdName=JR19860231, createdTime=Wed Jan 17 04:07:00 CST 2018, time=2018-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009679, encodeId=0ffa20096e9b6, content=<a href='/topic/show?id=c7804e581bc' target=_blank style='color:#2F92EE;'>#局灶性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47581, encryptionId=c7804e581bc, topicName=局灶性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Mon Jul 16 11:07:00 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473448, encodeId=3e4f14e3448a2, content=<a href='/topic/show?id=4fd1e102257' target=_blank style='color:#2F92EE;'>#病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71022, encryptionId=4fd1e102257, topicName=病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8ce7226273, createdName=jktdtl, createdTime=Sat Oct 28 01:07:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495381, encodeId=a15114953817f, content=<a href='/topic/show?id=cdd8556826f' target=_blank style='color:#2F92EE;'>#抗药性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55682, encryptionId=cdd8556826f, topicName=抗药性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=110a9169530, createdName=songbq, createdTime=Sat Oct 28 01:07:00 CST 2017, time=2017-10-28, status=1, ipAttribution=)]
    2017-10-28 songbq

相关资讯

2017 安大略癫痫小组建议:癫痫儿童到成人过渡的护理

癫痫是儿童时期常见的一种慢性神经疾病,本文主要针对儿童癫痫患者从儿童过渡到成人时期的护理提供指导,关键内容包括成人卫生保健系统的过渡程序应及早开始;过渡时期是重新考虑诊断和管理的理想时间;心理社会筛查应该再离开儿童卫生保健系统之前开始。

这个位置的异常,竟然导致患者抽搐了6年

患者为51岁男性,自述出生后不久出现抽搐发作1次,以后再未出现抽搐,最近6年时间间断抽搐,一直未能检查出原因,药物治疗效果欠佳,此次为了彻底查明病因入院。

颅脑创伤后癫痫防治共识发布

《颅脑创伤后癫痫(PTE)防治中国专家共识》日前发布。该《共识》由中华医学会神经外科分会神经创伤专业组、中华医学会创伤学分会颅脑创伤专业组,组织国内77位神经外科专家编写而成。

JAMA Neurol:连续脑电图分析用于危重患者急性癫痫发作风险评估

研究开发了有效的危重患者急性癫痫发作概率评估模型,该方法将有助于患者的临床管理

Ann Neurol:孕期抗癫痫药物对胎儿发育以及早产的影响

研究认为,对于孕期服用抗癫痫药物的女性,无论其是否出现癫痫发作指征,均会导致早产或低胎龄风险升高

NEJM:儿童耐药性癫痫的手术治疗

研究认为,神经外科手术联合药物治疗可以显著缓解耐药性儿童癫痫患者的症状,术后不良事件与手术区域相关